We serve Chemical Name:5-Fluoro-2-pyrimidinecarbonitrile CAS:38275-55-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Fluoro-2-pyrimidinecarbonitrile
CAS.NO:38275-55-7
Synonyms:2-Pyrimidinecarbonitrile, 5-fluoro-;5-Fluoro-2-pyrimidinecarbonitrile;5-Fluoropyrimidine-2-carbonitrile
Molecular Formula:C5H2FN3
Molecular Weight:123.088
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:255.7±32.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.508
PSA:49.57000
Exact Mass:123.023277
LogP:-0.03
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Pyrimidinecarbonitrile, 5-fluoro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Fluoropyrimidine-2-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Fluoropyrimidine-2-carbonitrile Use and application,5-Fluoropyrimidine-2-carbonitrile technical grade,usp/ep/jp grade.
Related News: Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development. 5-Fluoro-2-pyrimidinecarbonitrile manufacturer Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. 5-Fluoro-2-pyrimidinecarbonitrile supplier For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. 5-Fluoro-2-pyrimidinecarbonitrile vendor For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. 5-Fluoro-2-pyrimidinecarbonitrile factory China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.
